MJ Fox Foundation researching possible higher Parkinson’s risk for Jews

News

Author: Parkinson's Life editorsPublished: 15 April 2016

Prep: Cook: Serves:

The incidence of mutated genes that can develop into Parkinson’s disease in Jews is being researched by The Michael J Fox Foundation.

The biggest genetic indicator of Parkinson’s is 10 times more prevalent in Ashkenazi Jews than in the general population, research has revealed.

A new global study will track how often mutated LRRK2 genes – which are present in 10 per cent of Ashkenazim – develops into the disease. A second mutated gene called GBA was also found to be more common in this ethnic group. A saliva test can show whether a patient has these mutated genes.

Gemma Loebenberg, a specialist at the National Institute of Health Research, which leads this investigation, said: “People who have one of those genes have a 50 per cent chance of passing it to their children.”

She called on Jews with Parkinson’s, or who have relatives with the condition, to volunteer for the study.

Last Month

Next Month

Go Back

Share this story

Comments

Global update

Dave Clark marches for a Parkinson’s cure

The former sports commentator’s latest fundraiser for Parkinson’s

Watch: “Gotta Keep Moving”

A new documentary follows social worker Margie Alley after her diagnosis

Muhammad Ali’s daughter: “Dad, you are a pearl embedded in the oyster of life”

WPC highlights: May May Ali and Brian Grant at the opening ceremony

Study suggests why neurons die in Parkinson’s disease

Researchers at the University of Córdoba, Spain, have discovered how a certain protein may be linked to death of dopamine-producing neurons associated with Parkinson’s. Using animal models of the condition to conduct their study, the team focused on the protein DJ-1 – whose link to Parkinson’s has previously been established, though its exact function was uncertain. The researchers compared neurons in the brains of mice that possessed the gene expressing DJ-1 with those that did not. The findings revealed that dysfunction or absence of the gene expressing the DJ-1 protein could trigger the ‘cell cycle’ (the process by which cells divide), which should not occur under normal conditions. Because neurons lack the capacity to divide, this causes them die – leading to the onset of symptoms linked with Parkinson’s. It is hoped that uncovering these details about the relationship between DJ-1’s absence and Parkinson’s may lead to the development of…

Researchers have finally identified brain cells linked to Parkinson’s disease

For decades, scientists have known that Parkinson’s is associated with the death of dopamine-producing cells in the brain. Now, researchers from the Broad Institute of MIT and Harvard, US, have discovered the specific subtype of brain cells that die in Parkinson’s disease. Using a technique called single-cell RNA signalling, which enables the individual analysis of cells within a tissue for activity and protein production, researchers identified 10 subtypes of dopamine-producing cells within the donated brains of people who died from causes unrelated to Parkinson’s. The team carried out the same investigation on people who had died with Parkinson’s or a condition with similar symptoms called Lewy body dementia. They discovered that only one subtype of the cells had reduced in number – which suggests many of these cells had died while the people were living. It is hoped that the findings could lead to better understanding of Parkinson’s causes and…

Tiny DBS implant shows potential to advance Parkinson’s disease treatment

In an innovative trial by North Bristol NHS Trust, UK, surgeons have succeeded in implanting a tiny deep brain stimulation (DBS) device into a person’s skull. Their aim? To address symptoms of Parkinson’s. Designed with a tiny battery system that is inserted into the skull, the DBS device delivers electric impulses to targeted areas of the brain through electric probes. In doing so, it works to address abnormal brain cell activity associated with Parkinson’s – and may help to ease symptoms. One of around 25 patients selected for the year-long trial has described the device’s impact as “amazing”. Commenting on the results of the trial so far, consultant neurologist Dr Alan Whone of North Bristol NHS Trust said: “We are hopeful that if these findings hold up, we will have a significant technical advance by which to improve Parkinson’s care across the world.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Name
This field is for validation purposes and should be left unchanged.

MJ Fox Foundation researching possible higher Parkinson’s risk for Jews

News

Author: Parkinson's Life editorsPublished: 15 April 2016

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Global update

Dave Clark marches for a Parkinson’s cure

Global update

Watch: “Gotta Keep Moving”

Global update

Muhammad Ali’s daughter: “Dad, you are a pearl embedded in the oyster of life”

Study suggests why neurons die in Parkinson’s disease

Researchers have finally identified brain cells linked to Parkinson’s disease

Tiny DBS implant shows potential to advance Parkinson’s disease treatment

{title}

Subscribe

MJ Fox Foundation researching possible higher Parkinson’s risk for Jews

News

Author: Parkinson's Life editorsPublished: 15 April 2016

Last Month

Next Month

Share this story

Comments

Related articles

Global update

Dave Clark marches for a Parkinson’s cure

Global update

Watch: “Gotta Keep Moving”

Global update

Muhammad Ali’s daughter: “Dad, you are a pearl embedded in the oyster of life”

Study suggests why neurons die in Parkinson’s disease

Researchers have finally identified brain cells linked to Parkinson’s disease

Tiny DBS implant shows potential to advance Parkinson’s disease treatment

{title}

Subscribe

Sign in